The effect of COVID-19 pandemics on the comprehensive laboratory diagnostic of alpha-1 antitrypsin deficiency in Europe - report from the AATD LABNet
J. Chorostowska-Wynimko (Warsaw, Poland), M. Balduyck (Lille, France), T. Carroll (Dublin, Ireland), T. Greulich (Marburg, Germany), N. Mcelvaney (Dublin, Ireland), M. Miravitlles (Barcelona, Spain), F. Rodriguez-Frias (Barcelona, Spain), M. Odou (Lille, France), S. Ottaviani (Pavia, Italy), D. Parr (Coventry, United Kingdom), A. Rozy (Warsaw, Poland), S. Seixas (Porto, Portugal), G. Orriols Torras (Barcelona, Spain), M. Veith (Marburg, Germany), F. Zerimech (Lille, France), A. Corsico (Pavia, Italy), I. Ilaria Ferrarotti (Pavia, Italy)
Source: International Congress 2022 – New insights and biomarkers in COPD
Session: New insights and biomarkers in COPD
Session type: Thematic Poster
Number: 1280
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Chorostowska-Wynimko (Warsaw, Poland), M. Balduyck (Lille, France), T. Carroll (Dublin, Ireland), T. Greulich (Marburg, Germany), N. Mcelvaney (Dublin, Ireland), M. Miravitlles (Barcelona, Spain), F. Rodriguez-Frias (Barcelona, Spain), M. Odou (Lille, France), S. Ottaviani (Pavia, Italy), D. Parr (Coventry, United Kingdom), A. Rozy (Warsaw, Poland), S. Seixas (Porto, Portugal), G. Orriols Torras (Barcelona, Spain), M. Veith (Marburg, Germany), F. Zerimech (Lille, France), A. Corsico (Pavia, Italy), I. Ilaria Ferrarotti (Pavia, Italy). The effect of COVID-19 pandemics on the comprehensive laboratory diagnostic of alpha-1 antitrypsin deficiency in Europe - report from the AATD LABNet. 1280
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|